Table 1.
Study | Joint | Number of spacer implantations | Cement used | Spacer type | Antibiotic impregnation and type |
---|---|---|---|---|---|
Anagnostakos et al. [6] | Hip | 17 | Palacos | Custom-made | 0.5 g G + 2 g V/40 g cement powder |
| |||||
Balato et al. [7] | 10x hip 8x knee |
18 | Palacos | Custom-made | 1 g G + 1 g C powder |
| |||||
Bertazzoni Minelli et al. [8] | 5x hip 6x knee |
11 | Cemex® | Prefabricated∗ | 1.9% G, 1.9% G + 1.25% V, 1.9% G + 1.9% V, 1.9% G + 2.5% V, 1.9% G + 5% V powder |
| |||||
Fink et al. [9] | Hip | 14 | Palacos | Custom-made | 7 × 1 g G + 1 g C/40 g cement, 7 x 1 g G + 1 g C + 2 g V/40 g cement powder |
| |||||
Hsieh et al. [10] | Hip | 46 | Simplex | Custom-made | 4 g V + 4 g A/40 g cement powder |
| |||||
Hsieh et al. [11] | Hip | 42 | Simplex | Custom-made | ~300 mg G + 3 g V/40 g cement liquid G + powder V |
| |||||
Isiklar et al. [12] | Hip | 10 | n.r. | Custom-made | 2 g V/40 g cement powder |
| |||||
Kelm et al. [13] | Hip | 10 | Palacos | Custom-made | 0.5 g G + 2 g V/40 g cement |
| |||||
Masri et al. [14] | 34x hip 15x knee |
49 | 37x Palacos 12x Simplex |
Custom-made | 1.2–4.8 g T + 1-2 g V/40 g cement powder |
| |||||
Mutimer et al. [15] | Knee | 12 | Cemex | Prefabricated | Gentamicin powder |
| |||||
Regis et al. [16] | Hip | 7 | Cemex | Prefabricated∗∗ | 2.5% G + 150–170 mg V powder |
V: vancomycin; G: gentamicin; C: clindamycin; A: aztreonam; T: tobramycin; ∗: in 9/11 cases additional impregnation by drilling in the spacer and filling with vancomycin-loaded cement; ∗∗: in all cases additional impregnation by drilling in the spacer and filling with vancomycin-loaded cement; n.r.: not reported.